Medical Xpress

FDA provides fast track designation to nipocalimab for systemic lupus erythematosus

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track ...

DOJ to Fast-Track Merger Probes by Curbing Information Requests

Merging companies will face less burdensome antitrust reviews from the Trump administration after the US Justice Department said it will fast-track investigations by reducing the amount of information ...
Yahoo Finance

FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy

RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to MTX-001, ...
Lupus Foundation of America

FDA Grants Fast Track Status to Telitacicept for Lupus Treatment

Telitacicept, an investigational drug by RemeGen, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) as a possible treatment for lupus. With its novel dual-target ...